Northstar Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,568
| Closed | -$140K | – | 130 |
|
|
2020
Q1 | $140K | Hold |
15,568
| – | – | 0.06% | 123 |
|
|
2019
Q4 | $153K | Hold |
15,568
| – | – | 0.06% | 130 |
|
|
2019
Q3 | $107K | Sell |
15,568
-5,000
| -24% | -$34.4K | 0.04% | 130 |
|
|
2019
Q2 | $190K | Buy |
20,568
+1,600
| +8% | +$14.8K | 0.08% | 133 |
|
|
2019
Q1 | $297K | Buy |
18,968
+3,500
| +23% | +$54.8K | 0.13% | 112 |
|
|
2018
Q4 | $239K | Buy |
15,468
+4,000
| +35% | +$61.8K | 0.12% | 114 |
|
|
2018
Q3 | $247K | Hold |
11,468
| – | – | 0.11% | 119 |
|
|
2018
Q2 | $279K | Hold |
11,468
| – | – | 0.14% | 112 |
|
|
2018
Q1 | $196K | Sell |
11,468
-7,000
| -38% | -$120K | 0.1% | 119 |
|
|
2017
Q4 | $276K | Sell |
18,468
-5,500
| -23% | -$82.2K | 0.15% | 101 |
|
|
2017
Q3 | $422K | Sell |
23,968
-80
| -0.3% | -$1.41K | 0.24% | 86 |
|
|
2017
Q2 | $799K | Buy |
24,048
+2,500
| +12% | +$83.1K | 0.49% | 58 |
|
|
2017
Q1 | $694K | Buy |
21,548
+8,750
| +68% | +$282K | 0.46% | 58 |
|
|
2016
Q4 | $464K | Buy |
+12,798
| New | +$464K | 0.32% | 70 |
|